| 1 |
31983575 | Effect of 5-lipoxygenase inhibitor, VIA-2291 (Atreleuton), on epicardial fat volume in patients with recent acute coronary syndrome. | 2020 Jul - Aug |
1 |
| 2 |
27883201 | Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study. | 2017 Apr |
2 |
| 3 |
25752438 | A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome. | 2015 May |
1 |
| 4 |
20190281 | Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome. | 2010 May |
2 |
| 5 |
11527015 | ABT-761 (Abbott). | 2001 Jan |
1 |
| 6 |
9569998 | Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers. | 1998 Apr |
2 |
| 7 |
9596112 | Effects of a 5-lipoxygenase inhibitor, ABT-761, on exercise-induced bronchoconstriction and urinary LTE4 in asthmatic patients. | 1998 Mar |
2 |
| 8 |
9702850 | Effects of ABT-761, a novel 5-lipoxygenase inhibitor, on the pharmacokinetics of a single dose of ethinyl estradiol and levonorgestrel in healthy female volunteers. | 1998 Jul |
2 |
| 9 |
9923573 | Pharmacokinetics of a novel 5-lipoxygenase inhibitor (ABT-761) in pediatric patients with asthma. | 1998 Nov-Dec |
1 |
| 10 |
10099073 | Lack of cytochrome P450 1A2 interaction effect of ABT-761 on the pharmacokinetics of theophylline. | 1998 Sep |
1 |
| 11 |
9117020 | The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects. | 1997 Mar |
1 |
| 12 |
9311617 | Improving the in vivo duration of 5-lipoxygenase inhibitors: application of an in vitro glucuronosyltransferase assay. | 1997 Sep |
1 |